Granules India And Jubilant Cadista Recall Products In US Market Kumar Jeetendra | September 13, 2021 Granules India and Jubilant Cadista, two generic drug manufacturers, are recalling several goods in the United States, the world’s largest market for medicines, for various reasons. According to the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), Granules India’s US-based unit is recalling over 1.14 crore Naproxen Sodium tablets, a non-steroidal …
Aurobindo Pharma gets USFDA gesture for malignancy treatment injection Kumar Jeetendra | August 27, 2021 New Delhi, Aug 27 (PTI) Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in the treatment of several types of cancer. The company”s subsidiary “Eugia Pharma Specialities Ltd has received a 505(b)(2) NDA approval from the US Food & …
Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars Kumar Jeetendra | August 25, 2021 Mumbai, India, August 25, 2021: Cipla Limited (BSE: 500087 | NSE: CIPLA EQ, hereafter referred to as “Cipla”), a leading global pharmaceutical company and Kemwell Biopharma Private Limited, a leading biopharmaceutical Contract Development and Manufacturing Organisation (CDMO), announced execution of a joint venture agreement to develop, manufacture and commercialise biosimilars for global markets. For this …
Pfizer,AstraZeneca COVID-19 vaccines less viable against Delta variation: Oxford-drove study Kumar Jeetendra | August 19, 2021 The COVID-19 vaccines by Pfizer and AstraZeneca are less effective against the Delta variant of coronavirus compared to the Alpha variant, according to a study led by researchers at the University of Oxford.The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new …
Pfizer submits information for third dose endorsement in US Kumar Jeetendra | August 17, 2021 Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their Covid-19 vaccine for all Americans. Last week, the United States approved the booster shot of Pfizer-BioNTech and Moderna vaccines for people with weakened immune systems. Pfizer and BioNTech …
Wockhardt inks agreement to deliver, supply Sputnik vaccine to Dubai-based firm Kumar Jeetendra | August 13, 2021 Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of COVID-19 vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF …
Cipla receives final approval for generic version of Durezol® Kumar Jeetendra | August 12, 2021 Mumbai, India; August 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated …
Provided more than 1 billion COVID-19 vaccine dose up until now: BioNTech Kumar Jeetendra | August 9, 2021 BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday. The supply tally, up from more than 700 million doses announced by the biotech firm in June, compares with AstraZeneca saying …
Alembic Pharma gets last approval from USFDA for OCD treatment drug Kumar Jeetendra | August 5, 2021 New Delhi, Aug 5 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Clomipramine Hydrochloride capsules, used for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The company has received final approval from the US Food and Drug Administration (USFDA) for …
Consolidating AstraZeneca and mRNA COVID-19 vaccine is effective – Danish study Kumar Jeetendra | August 2, 2021 Combining AstraZeneca’s COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca’s vaccine in …
India says Johnson and Johnson pulls out proposal for quick COVID-19 vaccine approval Kumar Jeetendra | August 2, 2021 India’s drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the …
Pharmaceutical Roots – Almonds and Enantiomers Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Mandelic acid Mandelic acid is a small, aromatic compound with many different uses. Although these days it is usually prepared in the lab, mandelic …
